✦ LIBER ✦

Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

✍ Scribed by Svenson, M.; Geborek, P.; Saxne, T.; Bendtzen, K.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with anti-TNF-α antibody infli

✍ Yasunori Kageyama; Masaaki Takahashi; Eiji Torikai; Motohiro Suzuki; Tetsuya Ich 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 108 KB

Letter: persistence of anti-infliximab a

✍ C. Steenholdt; J. Brynskov; K. Bendtzen 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Low infliximab serum trough levels and a

✍ Aatke van der Maas, Bart JF van den Bemt, Gertjan Wolbink, Frank HJ van den Hoog 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 162 KB

Letter: persistence of anti-infliximab a

✍ S. Ben-Horin; Y. Chowers 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Phosphatidylserine-dependent anti-prothr

✍ Karin Malíčková, Dana Ďuricová, Martin Bortlík, Ivana Janatková… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 182 KB

Long-term follow-up of patients treated

✍ Hanauer, Stephen B.; Schaible, Thomas F.; DeWoody, Kimberly L.; Marsters, Paul A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 181 KB